Quote:

---

In another, earlier study of metastatic brain cancer patients who received a single dose of focused RT after surgery, the control rate at one year for tumors 2.5 to 3.5 cm in size was 33 percent, according to Dr. Kotecha. “That means that roughly a third of the patients survived at least 12 months following treatment without suffering a tumor recurrence in the surgical site,” he says.

---

Add some leronlimab to that treatment and see what you get. Stop the metastasis and strip away tumor defenses so microglia can kill them.